









市场行情
/
股票
/
nasdaq-holx
/

Hologic Inc

HOLX

75.190USD

+0.190+0.25%

收盘 12/15, 16:00（美东）报价延迟15分钟

16.73B总市值

30.06市盈率 TTM



Hologic Inc

75.190

+0.190+0.25%

概览公司财务分析

概览

公司

财务

分析

关于 Hologic Inc 公司

Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.

Hologic Inc简介



公司代码HOLX

公司名称Hologic Inc

上市日期Mar 01, 1990

CEOMacmillan (Stephen P)

员工数量7070

证券类型Ordinary Share

年结日Mar 01

公司地址250 Campus Drive

城市MARLBOROUGH

上市交易所NASDAQ OMX - NASDAQ BASIC

国家United States of America

邮编01752

电话15082632900

网址https://www.hologic.com/

公司代码HOLX

上市日期Mar 01, 1990

CEOMacmillan (Stephen P)

Hologic Inc公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Stephen P. (Steve) Macmillan

Chairman of the Board, President, Chief Executive Officer

1.41M

+15.48%

Mr. Essex D. Mitchell

Chief Operating Officer

59.18K

+495.99%

Ms. Christiana Stamoulis

Independent Director

47.34K

Mr. Mark Horvath

Division President, Breast and Skeletal Health Solutions

22.79K

+222.98%

Mr. Charles J. Dockendorff, CPA

Independent Director

18.81K

+11.00%

Mr. Brandon Schnittker

Division President, GYN Surgical Solutions

17.60K

+188.84%

Ms. Diana De Walt

Senior Vice President - Human Resources

12.02K

Dr. Ludwig N. Hantson, Ph.D.

Independent Director

9.26K

+25.20%

Ms. Nanaz Mohtashami

Independent Director

4.18K

+80.45%

Ms. Stacey D. Stewart

Independent Director

3.60K

+107.62%

名称

名称/职务

职务

持股

持股变动

Mr. Stephen P. (Steve) Macmillan

Chairman of the Board, President, Chief Executive Officer

1.41M

+15.48%

Mr. Essex D. Mitchell

Chief Operating Officer

59.18K

+495.99%

Ms. Christiana Stamoulis

Independent Director

47.34K

Mr. Mark Horvath

Division President, Breast and Skeletal Health Solutions

22.79K

+222.98%

Mr. Charles J. Dockendorff, CPA

Independent Director

18.81K

+11.00%

Mr. Brandon Schnittker

Division President, GYN Surgical Solutions

17.60K

+188.84%

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Disposables

658.40M

64.31%

Service

208.80M

20.39%

Capital equipment, components and software

152.00M

14.85%

Other

4.60M

0.45%

地区USD

名称

营收

占比

United States

760.70M

74.30%

Europe

148.10M

14.47%

Asia

60.30M

5.89%

Rest of World

54.70M

5.34%

业务

地区

业务USD

名称

营收

占比

Disposables

658.40M

64.31%

Service

208.80M

20.39%

Capital equipment, components and software

152.00M

14.85%

Other

4.60M

0.45%

股东统计

更新时间: 11月16日周日

持股股东

股东类型

持股股东

占比

The Vanguard Group, Inc.

11.71%

T. Rowe Price Investment Management, Inc.

9.67%

BlackRock Institutional Trust Company, N.A.

5.58%

Manulife Investment Management (North America) Limited

4.69%

State Street Investment Management (US)

4.48%

其他

63.87%

持股股东

占比

The Vanguard Group, Inc.

11.71%

T. Rowe Price Investment Management, Inc.

9.67%

BlackRock Institutional Trust Company, N.A.

5.58%

Manulife Investment Management (North America) Limited

4.69%

State Street Investment Management (US)

4.48%

其他

63.87%

股东类型

持股股东

占比

Investment Advisor

57.09%

Investment Advisor/Hedge Fund

28.17%

Hedge Fund

6.68%

Research Firm

2.40%

Pension Fund

2.30%

Bank and Trust

1.74%

Sovereign Wealth Fund

1.26%

Individual Investor

1.03%

Family Office

0.05%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

1587

223.55M

100.44%

-14.31M

2025Q2

1594

230.47M

103.62%

-13.07M

2025Q1

1635

231.71M

103.94%

-14.47M

2024Q4

1617

238.36M

106.18%

-10.05M

2024Q3

1583

240.17M

103.42%

-3.00M

2024Q2

1580

234.77M

100.61%

-6.88M

2024Q1

1595

233.34M

99.37%

-7.61M

2023Q4

1584

235.52M

98.14%

-14.13M

2023Q3

1574

242.15M

98.88%

-13.93M

2023Q2

1583

245.52M

99.77%

-12.39M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

The Vanguard Group, Inc.

26.70M

12%

-16.89K

-0.06%

Jun 30, 2025

T. Rowe Price Investment Management, Inc.

24.08M

10.83%

+6.39M

+36.15%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

12.95M

5.82%

-509.21K

-3.78%

Jun 30, 2025

Manulife Investment Management (North America) Limited

11.02M

4.96%

+8.23M

+294.34%

Jun 30, 2025

State Street Investment Management (US)

10.10M

4.54%

-14.24K

-0.14%

Jun 30, 2025

Geode Capital Management, L.L.C.

5.83M

2.62%

+97.14K

+1.69%

Jun 30, 2025

Victory Capital Management Inc.

5.50M

2.47%

-1.11M

-16.81%

Jun 30, 2025

Invesco Advisers, Inc.

4.33M

1.95%

+3.88M

+868.40%

Jun 30, 2025

Black Creek Investment Management, Inc.

4.03M

1.81%

+832.44K

+26.05%

Jun 30, 2025

Citadel Advisors LLC

3.71M

1.67%

+3.45M

+1342.24%

Jun 30, 2025

持股ETF



更新时间: 12月6日周六

机构名称

占比

First Trust Nasdaq Lux Digi Health Solutions ETF

4.41%

LeaderShares AlphaFactor Tactical Focused ETF

3.17%

John Hancock Fundamental All Cap Core ETF

3.15%

AltShares Event-Driven ETF

2.95%

ProShares Merger ETF

2.78%

First Trust Indxx Medical Devices ETF

2.19%

Strategas Global Policy Opportunities ETF

2.08%

State Street SPDR S&P Health Care Equipment ETF

2.02%

iShares U.S. Medical Devices ETF

1.95%

Brandes US Small-Mid Cap Value ETF

1.94%

First Trust Nasdaq Lux Digi Health Solutions ETF

占比4.41%

LeaderShares AlphaFactor Tactical Focused ETF

占比3.17%

John Hancock Fundamental All Cap Core ETF

占比3.15%

AltShares Event-Driven ETF

占比2.95%

ProShares Merger ETF

占比2.78%

First Trust Indxx Medical Devices ETF

占比2.19%

Strategas Global Policy Opportunities ETF

占比2.08%

State Street SPDR S&P Health Care Equipment ETF

占比2.02%

iShares U.S. Medical Devices ETF

占比1.95%

Brandes US Small-Mid Cap Value ETF

占比1.94%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

常见问题

Hologic Inc的前五大股东是谁？



Hologic Inc 的前五大股东如下：
The Vanguard Group, Inc.持有股份：26.70M，占总股份比例：12.00%。
T. Rowe Price Investment Management, Inc.持有股份：24.08M，占总股份比例：10.83%。
BlackRock Institutional Trust Company, N.A.持有股份：12.95M，占总股份比例：5.82%。
Manulife Investment Management (North America) Limited持有股份：11.02M，占总股份比例：4.96%。
State Street Investment Management (US)持有股份：10.10M，占总股份比例：4.54%。